Galectin Therapeutics Ownership Structure: Retail Investors Hold 55%, Insiders Have 20% Stake.

Galectin Therapeutics Inc.'s top owners are retail investors with a 55% stake, while 20% is held by insiders. The top 25 shareholders own 43% of the business. Insiders have recently bought shares, suggesting potential future growth. Retail investors' significant ownership suggests that key decisions may be influenced by the larger public.